Latest Breaking News On - Shunt system - Page 1 : comparemela.com

CereVasc Announces $70 Million Series B Financing to Advance its Novel eShunt® System for the Treatment of Normal Pressure Hydrocephalus

CereVasc Announces $70 Million Series B Financing to Advance its Novel eShunt® System for the Treatment of Normal Pressure Hydrocephalus
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesTufts medical centerDan levangieCarl heilmanPiper sandlerAdel malekEvan greifCompany contactsPrnewswire cerevasc incBain capital life sciencesCerevasc incPerceptive xontogeny venture fundVasc announcesSeriesb financingNormal pressureShunt system

CereVasc Raises $70M in Series B Financing

CereVasc Raises $70M in Series B Financing
finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.

United statesEvan greifDan levangieBain capital life sciencesPerceptive xontogeny venture fundVice presidentShunt systemNormal pressure

CereVasc s eShunt® System Study Data Presented at the ABC WIN Seminar

/PRNewswire/ CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, announced that data from its.

Tufts medical centerUnited statesBuenos airesDistrito federalAdel malekPedro lylykIvan lylykDan levangieCarl heilmanCompany contactsPrnewswire cerevasc incCerevasc incShunt systemNormal pressure hydrocephalusClinical experienceCommunicating hydrocephalus

CereVasc eShunt® System Study Data Presented at Congress of Neurological Surgeons Meeting

/PRNewswire/ CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, announced that data from.

United statesTufts medical centerDan levangieAdel malekCarl heilmanPrnewswire cerevasc incCompany contactsCerevasc incShunt systemNeurological surgeonsAnnual meetingCerevasc chief medical officerPercutaneous endovascular biomimetic shuntShunt implantAneurysmal subarachnoid hemorrhage communicatingInvasive treatment

CereVasc Receives FDA IDE Approval to Expand its Clinical Study of Patients with Normal Pressure Hydrocephalus Utilizing the Generation 2 eShunt® System

/PRNewswire/ CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, announced that the U.S. Food.

United statesTufts medical centerPedro lylykCarl heilmanAdel malekDan levangieCerevasc incDrug administrationCompany contactPrnewswire cerevasc incShunt systemNormal pressure hydrocephalusShunt implantCerevasc presidentNeurovascular surgery